Niedrig maligne endometriale Stromasarkome

Zusammenfassung

Niedrig maligne endometriale Stromasarkome (NMESS) sind seltene sexualhormonabhängige Tumoren zumeist prämenopausaler Frauen. Sie kommen im Uterus und im Ovar, sehr selten auch in anderer Lokalisation vor. Die primäre Therapie ist chirurgisch. Standardoperation ist eine abdominale Hysterektomie mit bilateraler Salpingoophorektomie. Adjuvant ist in Abhängigkeit der Expression von Hormonrezeptoren eine Hormontherapie indiziert. Erfahrungen liegen mit Gestagenen und GNRH-Analoga vor. Der Benefit einer postoperativen Bestrahlung auf das Gesamtüberleben der Patientinnen ist bisher nicht bewiesen, ein effektives Chemotherapieregime nicht bekannt. Wichtigster Prognosefaktor ist das Tumorstadium. Bis zu 50 % aller NMESS rezidivieren. Die hohe Rezidivrate wird durch während der Operation zurückgelassene Tumorreste, die von der körpereigenen humoralen Abwehr nicht zerstört werden können, erklärt. Eine der anatomischen Ausbreitung angepasste Radikalität der operativen Behandlung ist deshalb ebenso notwendig wie eine lebenslange Tumornachsorge der Patientinnen.

Abstract

Low-grade endometrial stromal sarcomas (LGESS) are rare steroid-hormone dependent neoplasms, most of which arise in the uterus and ovaries of premenopausal women. If an LGESS is diagnosed preoperatively, hysterectomy with bilateral salpingoophorectomy is considered the standard therapy. For prognosis, tumor stage is the most important factor. Patients with LGESS suffer from a high recurrence rate up to 50 % which is believed to result from residual microscopic tumor islands. Adjuvant hormonal therapy may be indicated if the LGESS expresses hormone receptors. First promising results have been obtained with gestagen and GNRH-analoga therapy. Radiation therapy has no beneficial effect on overall survival, and an effective chemotherapy schema does not exist. Optimal treatment of patients is radical surgery and life-long oncological follow-up.

Uterus - Endometrium - Sarkom - Östrogenrezeptor - Progesteronrezeptor - Hormontherapie

Uterus - endometrium - sarcoma - oestrogen receptor - progesterone receptor - hormonal therapy

Literatur

• 1 Baggish M S, Woodruff J D. Uterine stromatosis: clinicopathologic features and hormone dependency.  Obstet Gynecol. 1972;  40 487-498
• 2 Baiocchi G, Kavanagh J J, Warton J T. Endometrioid stromal sarcomas arising from ovarian and extraovarian endometriosis: report of two cases and review of the literature.  Gynecol Oncol. 1990;  36 147-151
• 3 Beckmann M W, Jap D, Kuschel B, Dall P, Lux M P, Hanstein B, Bender H G. Ovarielle Steroidhormone und Anti-Östrogene: Risiken zu und Prävention in der Karzinogenese der Mamma und des Endometriums in der Postmenopause.  Geburtsh Frauenheilk. 2000;  60 77-85
• 4 Beckmann M W, Hanstein B, Niederacher D, Jap D, Kuschel B, Bender H G. Wirkmechanismen ovarieller Antiöstrogene in der Karzinogenese der Mamma und des Endometriums.  Geburtsh Frauenheilk. 2000;  60 71-76
• 5 Baker V V, Walton L A, Fowler W C, Currie J L. Steroid receptors in endolymphatic stromal myosis.  Obstet Gynecol. 1984;  63 72-74
• 6 Berchuck A, Rubin S C, Hoskins W J, Saigo P E, Pierce V K, Lewis Jr J L. Treatment of endometrial stromal tumors.  Gynecol Oncol. 1990;  36 60-65
• 7 Chang K L, Crabtree G S, Lim Tan S K, Kempson R L, Hendrickson M R. Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature.  Int J Gynecol Pathol. 1993;  12 282-296
• 8 Chang K L, Crabtree G S, Lim-Tan S K, Kempson R L, Hendrickson M R. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases.  Am J Surg Pathol. 1990;  14 415-438
• 9 Cummings S R, Eckert S, Krueger K A, Grady D, Powels T J, Cauley J A, Norton L, Nickelsen T, Bjarnason N H, Morrow M, Lippmann M E, Black D, Glusman J E, Costa A, Jordan V C. The effect of raloxifen on risk of breast cancer in postmenopausal women. Results from the MORE randomized trial.  JAMA. 1999;  281 2189-2197
• 10 Dorran A, Lockayer C. Two of cases of uterine fibroids showing peritheliomatous changes: long immunity from recurrence after operation.  Proc R Soc Med. 1908;  2 25-39
• 11 Echt G, Jepson J, Steel J, Langholz B, Luxton G, Hernandez W, Astrahan M, Petrovich Z. Treatment of uterine sarcomas.  Cancer. 1990;  66 35-39
• 12 Eddy G L, Mazur M T. Endolymphatic stromal myosis associated with tamoxifen use.  Gynecol Oncol. 1997;  64 262-264
• 13 Eldar-Geva T, Healy D L. Other medical management of uterine fibroids.  Baillieres Clin Obstet Gynaecol. 1998;  12 269-288
• 14 Füzesi L, Gunawan B, Braun S, Karl M C. Endometrial stromal sarcoma with clonal chromosomal aberrations and mixed phenotype.  Cancer Genet Cytogenet. 1995;  84 85-88
• 15 Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, Lissoni A, Losga G, Fanucci A. Endometrial stromal sarcoma: Analysis of treatment failures and survival.  Gynecol Oncol. 1996;  63 247-253
• 16 Gloor E, Schneyder P, Cikes M, Hofstetter J, Cordey R, Burnier F, Knobel P. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy.  Cancer. 1982;  50 1888-1893
• 17 Hendrickson M R, Kempson R L. Pure mesenchymal neoplasms of the uterine corpus. Fox H, Wells M Haines and Taylos Obstetrical and Gynecological Pathology. New York; Churchill Livingstone 1995: 19-86
• 18 Horowitz K, Rutherford T, Schwartz P E. Hormone replacement therapy in women with sarcomas.  CME J Gynecol Oncol. 1996;  1 23-29
• 19 Iliszko M, Mandahl N, Mrozek K, Denis A, Padis N, Pejovic T, Babinska M, Nedoszytko B, Debniak Jm Emerich J, Hranowska M, Bloomfield C D, Limon J. Cytogenetics of uterine sarcomas: Presentation of eight new cases and review of the literature.  Gynecol Oncol. 1998;  71 172-176
• 20 Kahanpaa K V, Wahlström T, Gröhn P, Heinonen E, Nieminen U, Widholm O. Sarcomas of the uterus: a clinicopathologic study of 119 patients.  Obstet Gynecol. 1986;  67 417-423
• 21 Katz L, Merino M J, Sakamoto H, Schwarz P E. Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors.  Gynecol Oncol. 1987;  26 87-97
• 22 Keen C E, Philip G. Progesterone-induced regression in low-grade endometrial stromal sarcoma. Case report and literature review.  Br J Obstet Gynaecol. 1989;  96 1435-1439
• 23 Knocke T H, Kucera H, Dörfler D, Pokrajac B, Pötter R. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.  Cancer. 1998;  83 1972-1979
• 24 Krieger P D, Gusberg S B. Endolymphatic stromal myosis - a grade I endometrial sarcoma.  Gynecol Oncol. 1973;  1 299-313
• 25 Krumholz B A, Lobovsky F Y, Halitsky V. Endolymphatic stromal myosis with pulmonary metastases. Remission with progestin therapy: Report of a case.  J Reprod Med. 1973;  10 85-89
• 26 Larson B, Silfversward C, Nielsson B, Pettersson F. Endometrial stromal sarcoma of the uterus. A clinical and histopathologic study. The Radiumhemmet series 1936 - 1981.  Europ J Obstet Gynecol Reprod Biol. 1990;  35 239-249
• 27 Lehrner L M, Miles P A, Enck R E. Complete remission of widely metastatic endometrial stromal sarcoma following combination chemotherapy.  Cancer. 1979;  43 1189-1194
• 28 Liokumovic P, Goldberg I, Davidson B, Gotlieb W H, Zahavi T, Ben-Baruch G, Reder I, Kopolovic J. Expression of metalloproteinases in endometrial stromal sarcoma: immunohistochemical study using image analysis.  J Clin Pathol. 1999;  52 198-202
• 29 Luo S, Martel C, Gauthier S, Merand Y, Belanger A, Labrie C, Labrie F. Long term effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice.  Int J Cancer. 1997;  73 735-739
• 30 Mansi J L, Ramachandra S, Wiltshaw E, Fischer C. Endometrial stromal sarcomas.  Gynecol Oncol. 1990;  36 113-118
• 31 Mesia A F, Demopoulos R I. Effects of leuprolide acetate on low-grade endometrial stromal sarcoma.  Am J Obstet Gynecol. 2000;  182 1140-1141
• 32 Miller W R, Mullen P, Telford J, Dixon J M. Clinical importance of intratumoral aromatase.  Breast Canc Res Treat. 1998;  49 27-32
• 33 Montag T W, Manart F D. Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.  Gynecol Oncol. 1989;  33 255-260
• 34 Norris H J, Tayler H B. Mesenchymal tumors of the uterus I. A clinical and pathologic study of 53 endometrial stromal tumors.  Cancer. 1966;  19 755-766
• 35 Pang L C. Endometrial stromal sarcoma with sex cord-like differentiation associated with tamoxifen therapy.  South Med J. 1998;  91 592-594
• 36 Pellillo D. Proliferative stromatosis of the uterus with pulmonary metastases. Remission following treatment with a long acting synthetic progestin: A case report.  Obstet Gynecol. 1968;  31 33-39
• 37 Piver M S, Rutledge F N, Copeland L, Webster K, Blumenson L, Suh O. Uterine endolymphatic stromal myosis: a collaborative study.  Obstet Gynecol. 1984;  64 173-178
• 38 Press M F, Scully R E. Endometrial “sarcomas” complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy.  Gynecol Oncol. 1985;  21 135-154
• 39 Rand R J, Lowe J W. Low-grade endometrial sarcoma treated with a progestagen.  Br J Hosp Med. 1990;  43 154-156
• 40 Reich O, Pickel H, Regauer S. Cytologic diagnosis of low-grade endometrial stromal sarcoma by staining for estrogen- and progesterone receptors.  Acta Cytol. 2002;  46 790-792
• 41 Reich O, Regauer S, Urdl M. Estrogen and progesterone receptor content in low-grade-stromal sarcomas.  Br J Cancer. 2000;  82 1030-1034
• 42 Reich O, Roitzsch E, Justus J. Die sogenannte Stromatosis uteri - ein niedrig malignes Sarkom - morphologische Studie anhand von 8 Falldarstellungen.  Zentralbl Gynäkol. 1994;  116 581-587
• 43 Remmele W, Schicketanz K H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer: computer-assisted image analysis (QIC score) vs. subjective grading (IRS).  Pathol Res Pract. 1993;  189 862-866
• 44 Scribiner D R, Walker H. Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Mecane.  Gynecol Oncol. 1998;  71 458-460
• 45 Scully R E, Bonfiglio T A, Kurman R J, Silverberg S G, Wilkinson E J. Histological Typing of Femal Genital Tract Tumors. Berlin; Springer 1994
• 46 Scully R E, Young R H, Clement P B. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube and Broad Ligament. Washington; Armed Forces Institute of Pathology 1998
• 47 Seidmann J D, Russel P, Kurmann R J. Surface epithelial tumors of the ovary. Kurmann RJ Blaustein's Pathology of the Female Genital Tract. Berlin; Springer 2001
• 48 Shiraki M, Otis C N, Powell J L. Endometrial stromal sarcoma arising from ovarian and extraovarian endometriosis - report of two cases and review of the literature.  Surg Pathol. 1991;  4 333-343
• 49 Silverberg S B, Kurman R J. Tumors of the Uterine Corpus and Gestational Throphoblastic Disease. Washington; Armed Forces Institute of Pathology 1992
• 50 Sonobe H, Iwata J, Furihata M, Ohtsuki Y, Taguchi T, Shimizu K. Endometrial stromal sarcoma with clonal complex chromosomal abnormalities.  Cancer Genet Cytogenet. 1999;  112 34-37
• 51 Sood A K, Sorosky J I, Gelder M S, Buller R E, Anderson B, Wilkinson E J, Benda J A, Morgan L S. Primary ovarian sarcoma. Analysis od prognostic variables and the role of surgical cytoreduction.  Cancer. 1998;  82 1731-1737
• 52 Styron S L, Burke T W, Linville W K. Low-grade endometrial stromal sarcoma recurring over three decades.  Gynecol Oncol. 1989;  35 275-278
• 53 Tsukamoto N, Kamura T, Matsukuma K, Imachi M, Uchino H, Saito T, Ono M. Endolymphatic stromal myosis: a case with positive estrogen and progesterone receptors and good responce to progestins.  Gynecol Oncol. 1985;  20 120-128
• 54 Walton L A, Siegfried J M, Nelson K G, Siegal G, Kaufmann D G. Endometrial stromal cells in culture: an attempt to understand the genesis and biologic activity of uterine sarcomas.  Gynecol Oncol. 1986;  24 247-257
• 55 Young R H, Prat J, Scully R E. Endometrioid stromal sarcomas of the ovary: a clinicopathologic analysis of 23 cases.  Cancer. 1984;  53 1143-1155
• 56 Zaloudek C, Hendrickson M R. Mesenchymal tumors of the uterus. Kurmann RJ Blaustein's Pathology of the Female Genital Tract. Berlin; Springer 2001